Do You Have Maintenance Patients Who Want an Alternative?

Consider the myfortic^® option

The enteric-coated formation of mycophenolate sodium that delivers the active moiety mycophenolic acid (MPA)

	Delayed-release enteric-coated tablets
	Effective therapy
	Smaller-sized tablet (360 mg myfortic compared to 500 mg MMF)   —21% smaller in width   —10% smaller in volume
	myfortic was designed to delay the release of the active moiety mycophenolic acid (MPA), until it reaches the small intestine

Click here for full prescribing information, which includes contraindications, warnings, precautions, and adverse events.